October 22, 2017 2:16 PM ET

Pharmaceuticals

Company Overview of Corcept Therapeutics Incorporated

Executive Profile

Charles B. Nemeroff M.D., Ph.D.

Member of Scientific Advisory Board, Corcept Therapeutics Incorporated
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 organization across 8 different industries.

See Board Relationships
67--

Background

Dr. Charles B. Nemeroff, M.D., Ph.D., is a Consultant to various pharmaceutical companies including Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Merck, Inc., Otsuka Pharmacia/Upjohn, Somerset Pharmaceuticals and Wyeth-Ayerst Laboratories. Dr. Nemeroff serves as the Editor-in-Chief of Neuropsychopharmacology. He has served as the Editor-in-Chief of the Psychopharmacology Bulletin, Associate Editor of Biological Psychiatry and both Critical Reviews in Neurobiology ...

Corporate Headquarters

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-327-3270
Fax: 650-327-3218

Board Members Memberships

2007-Present
Director

Education

MS
Northeastern University
BS
The City College of New York
Unknown/Other Education
University of North Carolina
PhD
University of North Carolina
MD
University of North Carolina

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$4.9M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Corcept Therapeutics Incorporated, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.